Disturbed sleep is a prominent feature of fibromyalgia symptomatology and has been proposed as one of the core symptoms that should be systematically assessed in clinical trials for the treatment ...

More than 93% of our patients report improvements in their symptoms, with many able to reduce or stop medications that cause adverse side effects. An impressive 45% of fibromyalgia patients have ...

Newer evidence has suggested, however, that gabapentin may not work for all pain conditions and is associated with falls. As ...

While these can be beneficial, it is important to ensure that they do not interact with any medications or exacerbate fibromyalgia symptoms. Magnesium supplements come in various forms such as ...

Growing awareness about fibromyalgia and advancements in treatment options drive market growth. Generic Medication Accessibility: Enhanced availability of generic medications for fibromyalgia ...

Recognizing these underlying principles is essential in devising holistic treatment approaches that address the multifaceted nature of fibromyalgia and empower individuals to regain control over ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

TNX-102 SL is a non-opioid, centrally-acting analgesic administered at bedtime for the treatment of fibromyalgia. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA ...

Fibromyalgia, the chronic pain condition that plagues approximately ten million Americans is in need of new drug treatment options. The existing approved drugs on the market often aren't enough.

The company has also submitted a New Drug Application to the U.S. Food and Drug Administration for TNX-102 SL, a non-opioid treatment for fibromyalgia. This is based on two Phase 3 studies showing ...

Axsome Therapeutics shows strong revenue growth with promising pipeline drugs for migraine, fibromyalgia, and narcolepsy.